Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Galimedix Therapeutics Inc

Clinical trials sponsored by Galimedix Therapeutics Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New eye drops aim to halt blinding disease in seniors Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Completed 1

New eye drops aim to halt blinding disease in seniors

Disease control Recruiting now

This study tests whether GAL-101 eye drops can slow the growth of geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. About 110 adults aged 55 and older with early-stage atrophy will use the drops or a placebo daily for up to two years…

Phase 2 • Sponsor: Galimedix Therapeutics Inc • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC